News & Insights

Hem Securities has come out with its report on Paradeep Phosphates. The research firm has recommended to #39;#39;Subscribe#39;#39; the ipo in its research report as on May 17, 2022.

Hem Securities has come out with its report on Paradeep Phosphates. The research firm has recommended to #39;#39;Subscribe#39;#39; the ipo in its research report as on May 17, 2022.

Hem Securities has come out with its report on Paradeep Phosphates. The research firm has recommended to #39;#39;Subscribe#39;#39; the ipo in its research report as on May 17, 2022.

Hem Securities has come out with its report on Ethos. The research firm has recommended to #39;#39;Subscribe#39;#39; the ipo in its research report as on May 17, 2022.

Ethos IPO: The company plans to garner Rs 472 crore through fresh issue of equity shares aggregating to Rs 375 crore and Rs 97.29 crore through the sale of 1,108,037 shares by the shareholders and promoters

Around 50 percent of the net offer will be reserved for QIBs, 35 percent for retail investors, and the remaining 15 percent for non-institutional investors.

The company aims to mop up Rs 1,501 crore by a combination of fresh issue of equity shares aggregating upto Rs 1,004 crore and an offer for sale (OFS) of 118,507,493 equity shares of Rs 10 each aggregating up to Rs 497.73 crore.

Choice Equity Broking has come out with its report on Ethos. The research firm has recommended to #39;#39;Avoid#39;#39; the ipo in its research report as on May 14, 2022.

Choice Equity Broking has come out with its report on Ethos. The research firm has recommended to #39;#39;Avoid#39;#39; the ipo in its research report as on May 14, 2022.

ICICI Direct has come out with its report on Ethos. The research firm has recommended to #39;#39;Avoid#39;#39; the ipo in its research report as on May 17, 2022.

Choice Equity Broking has come out with its report on Paradeep Phosphates. The research firm has recommended to #39;#39;Subscribe#39;#39; the ipo in its research report as on May 16, 2022.

Geojit has come out with its report on Paradeep Phosphates. The research firm has recommended to #39;#39;Subscribe#39;#39; the ipo in its research report as on May 16, 2022.

Qualified institutional buyers have, so far, subscribed only 36 percent of their quota of 10.14 lakh shares

The net fresh issue proceeds will be utilised for funding organic growth initiatives, and inorganic growth through acquisitions and other strategic initiatives, besides general corporate purposes.

The net fresh issue proceeds will be utilised for funding organic growth initiatives, and inorganic growth through acquisitions and other strategic initiatives, besides general corporate purposes.